Effect of Hypnosis on Adherence to Continuous Positive Airway Pressure.
Launched by SOLELHAC GEOFFROY · Apr 30, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether medical hypnosis can help patients stick to their Continuous Positive Airway Pressure (CPAP) therapy for sleep-disordered breathing, which includes conditions like obstructive sleep apnea. CPAP is a common treatment that helps keep airways open during sleep, but many patients struggle to use it effectively. The researchers believe that hypnosis might improve how patients feel about their treatment and encourage them to use the CPAP machine more consistently.
To participate in the trial, you need to be at least 18 years old and have been prescribed CPAP therapy but are currently using it for less than 3 hours a night on average. You also need to be willing to try hypnosis as part of the study. If you join, you can expect to learn self-hypnosis techniques that may help you feel more comfortable with your CPAP treatment, potentially leading to better sleep and overall health. The trial is currently recruiting, so if you or someone you know is having difficulty with CPAP, this might be an opportunity to explore a new approach.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥ 18 years of age
- • Indication for long-term CPAP treatment for sleep-disordered breathing.
- • Intolerance of CPAP with use of less than 3h/night on average (assessed at the second CPAP check-up by the home care provider 1 to 3 months CPAP introduction).
- • Ability to provide informed consent.
- Exclusion Criteria:
- • Patient's refusal to experience hypnosis.
About Solelhac Geoffroy
Solelhac Geoffroy is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a strong commitment to enhancing patient outcomes, the organization specializes in the design, management, and execution of clinical trials across various therapeutic areas. Leveraging a robust network of experts and state-of-the-art methodologies, Solelhac Geoffroy focuses on ensuring the highest standards of compliance and scientific rigor. Their mission is to facilitate the development of safe and effective therapies, ultimately contributing to the improvement of global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lausanne, Vaud, Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported